Emphasis on Disease Type (Acute Lymphocytic leukemia and Chronic Lymphocytic Leukemia); End-Users (Hospitals, Clinics, and Others); and Region/Country
The Brunkinsa Market was valued at USD 565 million in the year 2022 and is expected to grow at a strong CAGR of around 6% during the forecast period (2023-2030). Brukinsa is a medication used to treat acute lymphoblastic leukemia (ALL), a type of blood cancer that affects children and adults. The market for brukinza is growing rapidly due to the increasing prevalence of ALL and the growing awareness of the drug’s efficacy and safety. The global brukinza market is expected to grow significantly in the coming years, driven by the increasing demand for effective treatment options for ALL and the growing presence of key players in the market. The market is expected to be fueled by the increasing prevalence of ALL in developing countries, as well as the growing awareness of the drug’s efficacy and safety.
Some of the major players operating in the market include Bristol Myers Squibb; Celgene; Novartis; Pfizer; Merck; Johnson & Johnson; AstraZeneca; Roche; Gilead Sciences; and Sanofi. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Among disease type, the chronic lymphocytic leukemia segment is expected to grow at a fast rate during the forecast period”
Based on the disease type, the market is segmented into acute lymphocytic leukemia and chronic lymphocytic leukemia. Amongst these, the chronic lymphocytic leukemia segment is expected to grow at a fast rate during the forecast period. The CLL segment of the brukinza market is expected to grow significantly in the coming years due to the increasing prevalence of CLL and the growing awareness of the drug’s efficacy and safety. Brukinza is a targeted therapy that works by inhibiting the BCL-2 protein, which is involved in the regulation of cell death. This makes it an effective treatment option for CLL patients who have mutations in the BCL-2 gene.
“Amongst End-users, clinics are expected to grow with high CAGR during the forecast period”
Based on the end-users, the market has been classified into hospitals, clinics, and others. Among these, Clinics are expected to grow with a high CAGR during the forecast period. The clinics segment of the brukinza market is expected to be driven by the increasing demand for effective treatment options for ALL and CLL and the growing presence of key players in the market. The market is expected to be highly competitive, with a large number of key players operating in the market. These players include Bristol Myers Squibb, Celgene, Novartis, Pfizer, and Merck, among others. These companies are all significant players in the global pharmaceutical industry and are committed to developing innovative therapies for patients with ALL and CLL.
“Asia Pacific dominated the Brunkinsa market in 2022”
The Asia Pacific region is home to a large population and is expected to be a major market for brukinza due to the increasing prevalence of acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) in the region. The Asia Pacific brukinza market is expected to grow significantly in the coming years due to the increasing demand for effective treatment options for ALL and CLL and the growing awareness of the drug’s efficacy and safety. Brukinza is a targeted therapy that works by inhibiting the BCL-2 protein, which is involved in the regulation of cell death. This makes it an effective treatment option for patients with ALL and CLL
Brunkinsa Market Report Coverage
Reasons to buy this report:
Customization Options:
The global Brunkinsa market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to contact us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Impact Of Covid-19 On The Brukinsa Market
6. Brukinsa Market Revenue, 2020-2030f
7. Market Insights By Diseases Type
8. Market Insights By End-users
9. Market Insights By Region
10. Brukinsa Market Dynamics
11. Brukinsa Market Opportunities
12. Brukinsa Market Trends
13. Demand And Supply-side Analysis
14. Value Chain Analysis
15. Pricing Analysis
16. Strategic Insights
17. Competitive Scenario
18. Company Profiled
19. Disclaimer
Research Methodology for the Brunkinsa Market Analysis (2023-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global brunkinsa market were the three major steps undertaken to create and analyze the adoption of brunkinsa in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global brunkinsa market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the brunkinsa market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the brunkinsa market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as disease type and end-users. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the brunkinsa market. Further, we conducted factor analysis using dependent and independent variables such as disease type and end-users of the brunkinsa market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the brunkinsa market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global brunkinsa market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global brunkinsa market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the p product type, application, and distribution channel in the global brunkinsa market.
The main objective of the Global Brunkinsa Market Study
The current & future market trends of the global brunkinsa market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
